cedocard 40
j b tillotts limited - isosorbide dinitrate - tablets - 40 milligram
cedocard 5
j b tillotts limited - isosorbide dinitrate - tablets - 5 milligram
cedocard retard 20
j b tillotts limited - isosorbide dinitrate - tablets - 20 milligram
cystrin tablets 50 milligram
j b tillotts limited - oxybutynin hydrochloride - tablets - 50 milligram
diazoxide withdrawn form
j b tillotts limited - diazoxide - withdrawn form
asacol 800
tradis gat ltd - mesalazine - tablets enteric coated - mesalazine 800 mg - mesalazine - mesalazine - ulcerative colitis:-for the treatment of mild to moderate acute exacerbations. -for the maintenance of remission.crohn's disease:-for the treatment of acute episodes.
entocort cr 3mg capsules
de pharmaceuticals - budesonide - modified-release capsule - 3mg
mesalazine espl 1600mg modified-release tablets
espl regulatory consulting ltd - mesalazine - modified-release tablet - mesalazine 1600 milligram(s) - antidiarrheals, intestinal antiinflammatory/antiinfective agents
asacol
chiesi new zealand limited t/a emerge health - mesalazine 400mg - enteric coated tablet - 400 mg - active: mesalazine 400mg excipient: iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc sodium starch glycolate triethyl citrate - induction of remission of mild to moderate episodes of ulcerative colitis. maintenance of remission of ulcerative colitis.
asacol
chiesi new zealand limited t/a emerge health - mesalazine 800mg - enteric coated tablet - 800 mg - active: mesalazine 800mg excipient: iron oxide red iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate methacrylic acid copolymer povidone purified talc sodium starch glycolate triethyl citrate - ulcerative colitis: induction of remission of mild to moderate episodes. maintenance of remission.